🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are very happy to share our last manuscript of the year describing the comparative analysis of different mouse strains of premature aging. biorxiv.org/content/10.110…

Another fascinating pre-print from the Ocampo Lab looking at differences in epigenetic aging across different mouse models of accelerated aging Of the strains they studied (ERCC1, LAKI, POLG, XPG) only ERCC1 showed DNAm age acceleration ERCC1 strains have impaired DNA repair 👀

Hoy han venido a conocer los servicios y espacios del #PCA y la Universidad de Alicante UA la empresa suiza #Epiterna 👉Se dedica a la investigación y el desarrollo de productos y tecnologías con el objetivo de cuantificar y manipular el proceso de envejecimiento ua:emprende

We are excited to announce EPITERNA. A spin-off from the Ocampo Lab at Université de Lausanne. Using a unique high-throughput drug screening platform, EPITERNA is leveraging evidence-based science to create more time that matters for people and their pets. epiterna.com/news/create-mo…

Swiss startup Epiterna has raised €10m from the Spotify founder's investment firm to develop drugs to combat the effects of ageing sifted.eu/articles/prima…

New work from the Ocampo Lab and members of EPITERNA exploring the “dark side” of in vivo reprogramming. Just trying to better understand what happens when we reprogram living animals. Congratulations to everyone involved who are helping push the field forward!

Impressive work! Overwhelming amount of data, made possible by the amazing team Ocampo Lab. Special mention to Alba Vilchez Acosta, Sara Picó, PhD, and Gabi Desdín. nature.com/articles/s4358…

Very excited to share our Research Briefing where we discuss the latest paper from our lab regarding the “dark side” of in vivo reprogramming Gabi Desdín. Thank you to the amazing team @ocampoLab Parras Alberto Sara Picó, PhD Calida Mrabti nature.com/articles/s4358…

Great work, Congrats! biorxiv.org/content/10.110…

Our first blog post about our journey EPITERNA building a high-throughput screening platform for lifespan extending drugs is out! epiterna.substack.com/p/revolutionis…

Great review by patrick and Ada Nguyen on partial cellular reprogramming. A novel rejuvenation technology with a great history! onlinelibrary.wiley.com/doi/full/10.11…

The new Richard Miller / ITP results are finally published on Astaxanthin and Meclizine. 12% and 8% lifespan extension respectively. Details here: rapamycin.news/t/new-richard-…

fter crafting specific instructions, I generated this image using DALL-E AI to promote our paper nature.com/articles/s4358…. What do you think: am I a creator for designing it, or just a user of this AI tool?

This great work is the result when a talented bioinformatician (Kevin Perez ), an in vivo scientist (myself) collaborate under the supervision of Alejandro Ocampo. Many thanks to Sara Picó, PhD for her huge contribution during the revision and Prof Steve Horvath and colleges!

Being in the top 5% of V02 Max for the population means you are 5 times less likely to die over a 10-year time horizon compared to someone in the bottom 25%. There is almost nothing medicine that offers that kind of survival advantage.

Which is correct?

Full study link: nature.com/articles/s4358…

The researchers have used partial reprogramming to repair DNA damage in a mouse model. 🐭 lifespan.io/news/epigeneti… By Josh Conway Cheyenne Rechsteiner Francesco Morandini Parras Alberto Amin Haghani Prof Steve Horvath Alejandro Ocampo University of Rochester EPITERNA Altos Labs Université de Lausanne #aging #rejuvenation #OSKM #Yamanaka

Congrats Alba Vilchez Acosta and Sara Picó, PhD, fantastic work! It was smart to induce reprogramming exclusively in post-mitotic cells Ocampo Lab. Thrilled to have contributed to it! biorxiv.org/content/10.110…

Excited to announce @vivoarchitect is live! We link global firms with Europe's best mouse preclinical facilities. Swiss precision & ethics at lower costs. Check us out: vivoarchitect.ch. Let's innovate with integrity! #PreclinicalResearch #Mice #LifeSciences